NRP104 20 mg (Vyvanse 20 mg)

Generic Name: lisdexamfetamine

Pill imprint NRP104 20 mg has been identified as Vyvanse 20 mg.

Vyvanse is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Vyvanse 20 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Imprint Search

Images for NRP104 20 mg

Vyvanse
Generic Name:
lisdexamfetamine
Imprint:
NRP104
20 mg
Strength:
20 mg
Color:
Beige
Size:
15.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Shire US Inc.
National Drug Code (NDC):
59417-0102
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
ferrosoferric oxide
ferric oxide yellow
FD&C Red No. 3
FD&C Yellow No. 6

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)